InvestorsHub Logo
Followers 2768
Posts 77901
Boards Moderated 1
Alias Born 05/10/2007

Re: rambob post# 2674

Wednesday, 05/14/2008 2:10:43 PM

Wednesday, May 14, 2008 2:10:43 PM

Post# of 6825
Here's one from November 2007....

Currently available rapid tests for Chlamydia lack sensitivity and are not licensed for swab specimens, with the exception of the Handi-Lab test (Zonda, Moraga, CA)

http://www.bmj.com/cgi/content/full/bmj.39402.463854.AEv1

Reproducibility testing for Chlamydia Rapid Test
We found 100% concordance between the expected results and the results generated from randomised and masked panels by testers using the Chlamydia Rapid Test. A previous study in which a modified version of the Chlamydia Rapid Test was used for trachoma testing by four novice operators in Tanzania also showed excellent reproducibility.

Conclusions
The new Chlamydia Rapid Test evaluated in this study achieves relatively high diagnostic sensitivity and provides results within about 30 minutes. It is suitable as a primary diagnostic tool for Chlamydia infection and, in settings where access to nucleic acid amplification tests is limited or absent, could also be used as a screening tool, especially for high risk populations.




2008-The Rainmakers Moneymakers. stock symbol RAIN
http://investorshub.advfn.com/boards/board.asp?board_id=11575


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.